Transmission of varicella vaccine virus, Japan

Emerging Infectious Diseases

Volumn 15, Issue 10, 2009, Pages 1702-1703

  Otsuka, Taketo ^a,b   Gomi, Yasuyuki ^c,d   Inoue, Naoki ^e   Uchiyama, Makoto ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Yurin Hospital   (Japan)

^c Osaka University   (Japan)

^d Biken   (Japan)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CHICKENPOX VACCINE;

ANTIVIRAL THERAPY; CASE REPORT; CHICKENPOX; CHILD; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; JAPAN; LETTER; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; RASH; TREATMENT OUTCOME; VARICELLA ZOSTER VIRUS; VIRUS DETECTION; VIRUS GENE; VIRUS STRAIN; VIRUS TRANSMISSION;

CHICKENPOX; CHICKENPOX VACCINE; CHILD, PRESCHOOL; FEMALE; HERPESVIRUS 3, HUMAN; HUMANS; MALE;

EID: 70349976556     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1510.090597     Document Type: Letter

References (10)

1. Marin M, Güris D, Chaves SS, Schmid S, Seward JF; Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-4):1-40.
2. Galea SA, Sweet A, Beninger P, Steinberg SP, Larussa PS, Gershon AA, et al. The safety profile of varicella vaccine: a 10- year review. J Infect Dis. 2008;197(Suppl 2):S165-9. DOI: 10.1086/522125 (Pubitemid 351590166)
3. Lau YL, Vessey SJ, Chan IS, Lee TL, Huang LM, Lee CY, et al. A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children. Vaccine. 2002;20:2942-2949 DOI: 10.1016/S0264-410X(02)00245-1
4. Gomi Y, Sunamachi H, Mori Y, Nagaike K, Takahashi M, Yamanishi K. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol. 2002;76:11447-11459 DOI: 10.1128/JVI.76.22.11447-11459. 2002 (Pubitemid 35231301)
5. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg SP, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol. 1992;66:1016-1020
6. Chaves SS, Haber P, Walton K, Wise RP, Izurieta HS, Schmid DS, et al. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis. 2008;197(Suppl 2):S170-7. DOI: 10.1086/522161
7. Brunell PA, Argaw T. Chickenpox attributable to a vaccine virus contracted from a vaccinee with zoster. Pediatrics. 2000;106:e28. DOI: 10.1542/peds.106.2.e28
8. Grossberg R, Harpaz R, Rubtcova E, Loparev V, Seward JF, Schmid DS. Secondary transmission of varicella vaccine virus in a chronic care facility for children. J Pediatr. 2006;148:842-844 DOI: 10.1016/j.jpeds.2006.01.038 (Pubitemid 43870088)
9. Sauerbrei A, Rubtcova E, Wutzler P, Schmid DS, Loparev VN. Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster. J Clin Microbiol. 2004;42:5604-5608 DOI: 10.1128/JCM.42.12.5604-5608. 2004 (Pubitemid 39664343)
10. Quinlivan ML, Gershon AA, Al Bassam MM, Steinberg SP, LaRussa P, Nichols RA, et al. Natural selection for rashforming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts. Proc Natl Acad Sci U S A. 2007;104:208-212 DOI: 10.1073/ pnas.0605688104 (Pubitemid 46068010)